Cannabis Science, Inc., World AIDS Institute and Timothy Ray Brown Foundation Hold Special Event Tomorrow, December 15, in Las Vegas: 'All I Want For Christmas is a Cure'

LAS VEGAS, Dec. 14, 2012 /PRNewswire/ -- Cannabis Science, Inc. (NASD OTC:  CBIS) and non-profits World AIDS Institute and Timothy Ray Brown Foundation team up to raise awareness of the promise of ground-breaking Cannabinoid-based treatment of cancer, including HIV-related cancers such as Kaposi's Sarcoma, and other HIV-related ailments.  The event is hosted by Timothy Ray Brown (the Berlin Patient), the first person in the world cured of HIV and Founder of the Timothy Ray Brown Foundation of the World AIDS Institute, a non-profit organization based in Washington, D.C., and Craig A. Rodgers, a patient, advocate, and survivor of life-threatening brain cancer currently being treated with novel Cannabinoid-based therapies.

"Event hosts Timothy Ray Brown and Craig A. Rodgers each represent the critical importance of personal courage and innovative medical therapies.  Timothy's HIV cure came from an oncologist thinking 'outside of the box'. And following complex brain surgery, Craig's inspiring response to cannabinoid-based treatment demonstrates the promise to cancer patients of the use of cannabinoids and the critical importance of research into their medicinal value," said Robert J. Melamede, Ph.D., President and CEO of Cannabis Science, Inc.   

"Timothy and Craig are both courageous fighters against life-threatening disease, and both are alive today because of cutting-edge approaches to scientific and medical challenges," said David W. Purdy, Founder and CEO of the World AIDS Institute and a Co-Founder of the Timothy Ray Brown Foundation.  "We are pleased to be working alongside Cannabis Science, a leader in advancing promising treatments for HIV and HIV-related diseases, such as Kaposi's Sarcoma, one of the leading causes of HIV-related deaths in the world."

Timothy Ray Brown, the first person to be cured of HIV in 2007 following a creatively-conceived stem cell transplant procedure that saved him from leukemia, announced the establishment of The Timothy Ray Brown Foundation with the World AIDS Institute on July 24, 2012 during the 19^th International AIDS Conference.  As the first and only non-profit organization in the 31-year history of AIDS created with the sole mission of finding a cure, its central goal is to secure funding and support cutting-edge therapies.  One journalist's reporting about Timothy's inspiring story and discussion of his HIV (and cancer) cure may be viewed at http://cupwire.hotink.net/articles/53147. Also see the World AIDS Institute / Timothy Ray Brown Foundation website at www.worldaidsinstitute.org.

Craig A. Rodgers, diagnosed with an inoperable and deadly brain tumor in 2006, found a pioneering surgeon who saved Craig's life, making him only the 51st person to successfully undergo this particular risky brain surgery. Craig also survived a second brain surgery in December 2011.  After his own research and advice from others, Craig decided to treat himself primarily with cannabis and cannabinoid products rather than with more traditional therapies.  While Craig still lives with 20 percent of the cancerous tumor, there has been no new growth in 2012.  He is a fierce advocate for "curing it forward," as he says.  Craig's courageous story may be viewed at www.craigrodgers.com.

The Timothy Ray Brown Foundation's mission is to procure funding and provide support for innovative technologies and treatments to find a cure for HIV and AIDS. Follow on Twitter at @TRBFoundation and on Facebook at http://www.facebook.com/TimothyRayBrownFoundation.

The World AIDS Institute's mission is to document and preserve the global history of AIDS, to inspire action today to improve the lives of people living with HIV and AIDS, and to strengthen the spectrum of innovative initiatives to find a cure.  Follow on Facebook at http://www.facebook.com/WorldAIDSInstitute.

Cannabis Science, Inc. is at the forefront of cannabinoid research and development for unmet medical needs. The Company works with leading experts in HIV drug development, medicinal characterization, and clinical research to develop, produce, and commercialize Phytocannabinoid-based pharmaceutical products.  Learn more at www.cannabisscience.com.

Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

Contact:
Cannabis Science Inc.
Dr. Robert J. Melamede, 1-888-889-0888
President & CEO
[email protected]
www.cannabisscience.com
or
Robert Kane, 1-561-234-6929
VP Investor Relations
[email protected]
[email protected]
www.cannabisscience.com

SOURCE Cannabis Science, Inc.